Davis Wright Tremaine LLP Davis Wright Tremaine LLP
Practice Areas - HIPAA/advisory bulletins
Home

Practice Areas - HIPAA

 

Legal Services

Related Practice Areas

Advisory Bulletins

Publications & Resources

HIPAA Search
 

 
News to Use
Recruiting
DWT in the Community
Seminars & Training
Bookstore
Lawyer Directory
Office Locations
Search & Site Map

HIPAA Articles

PROVISIONS OF HIPAA UNDER WHICH INFORMATION
MAY BE DISCLOSED FOR RESEARCH PURPOSES

Reproduced with permission from Medical Research Law & Policy Report, Vol. 2, No. 1, 76-77 (Jan. 15, 2003).
Copyright 2003 by The Bureau of National Affairs, Inc. (800-372-1033)

Type of PHI or Information Disclosed Purposes or Action Required Individual Authorization Required Under §164.508 Minimum Necessary Standard Applies §164.502(b)., §164.514(d) Accounting Under §164.528 for a Period of 6 Years From Disclosure
De-Identified Data Remove all identifiers pursuant to §164.514(b)(2). No. Can also disclose without authorization to a business associate (subject to the applicable regulations) solely for the purposes of the business associate carrying out the de-identification. No, because properly de-identified information no longer is PHI. No
"Statistical" Determination That Information is Not PHI An expert meeting the standards of § 164.514(b)(1) determines using statistical and scientific methods that the risk is very small that the information used alone or in combination with reasonably available information would permit recipient to identify the individual subject of the information. No. The expert is opining that the information is not PHI. No, because the information is de-identified and no longer PHI. No
For Public Health Activities
  • Disclosures to public registries [§164.514(b)(i)]
  • Disclosures for FDA safety monitoring purposes [§164.514(b)(iii)]
  • Disclosures for other public health activities or as required by law, as defined by the regulation.
No Yes, but a covered entity can rely on the requesting public health authorities minimum necessary determination. For routine and recurring disclosures, covered entities may develop standard protocols that address the types and amounts of PHI to be disclosed. Yes, but see special provisions at §164.528(b)(3) if multiple disclosures have been made to the same person or entity for a single purpose under § 164.512, which includes disclosures for public health activities.
Limited Data Set
  • Disclosures to private registries
  • Remove all facial identifiers pursuant to §164.514(e)
  • Enter into a Data Use Agreement that meets the standards of §164.514(e).
No. Can also disclose without authorization to a researcher (acting as a business associate, subject to the business associate regulations) solely for the purposes of such business associate creating the limited data set. Yes No
For Research Purposes Upon IRB or Privacy Board Waiver
  • Authorization can be waived or modified in accordance with § 164.512(i)(1)(i)
  • Waiver must be documented in accordance with § 164.512(i)(2)
As waived or modified by the IRB or Privacy Board. Yes Yes, but see special provisions at §164.528(b)(4)(i) if disclosures have been made for 50 or more persons for a particular research purpose during an accounting period.
Activities Preparatory to Research Under §164.512(i)(1)(ii)
  • Representations must be obtained from the researcher that the PHI is sought for activities preparatory to research and is necessary for research; and
  • PHI must not be removed from premises.
No Yes Yes, but see special provisions at §164.528(b)(4)(i) if disclosures have been made for 50 or more persons for a particular research purpose during an accounting period.
Research on Decedent's PHI Under § 164.512(i)(1)(iii)

  • Representations must be obtained from the researcher that
  • the PHI is sought solely for research on PHI of decedents
  • Researcher will provide documentation of death of individuals if requested,
  • The PHI is necessary for research.
No Yes Yes, but see special provisions at §164.528(b)(4)(i) if disclosures have been made for 50 or more persons for a particular research purpose during an accounting period.
With Individual Authorization Can be combined with an informed consent form, but must meet requirements of §164.508. Yes, but can be for open ended period (such as "until study is completed" or "none"). No No



Reproduced with permission from Medical Research Law & Policy Report, Vol. 2, No. 1, 76-77 (Jan. 15, 2003).
Copyright 2003 by The Bureau of National Affairs, Inc. (800-372-1033)

Our purpose in publishing this article is to inform our clients and friends of recent developments in HIPAA. It is not intended, nor should it be used, as a substitute for specific legal advice as legal counsel may only be given in response to inquiries regarding particular situations.

 

return to Publications main page

Davis Wright Tremaine LLP
Home | Practice Areas | News To Use | Recruiting | DWT in the Community
Seminars & Training | Bookstore | Lawyer Directory | Office Locations | Search & Site Map
Davis Wright Tremaine LLP Davis Wright Tremaine LLP
return to Publications main page